Intact cross-talk between insulin secretion and insulin action after postgastroplasty recovery of ideal body weight in severely obese patients

International Journal of Obesity

Volumn 28, Issue 6, 2004, Pages 821-823

  Letiexhe, M R ^a   Desaive, C ^a   Lefebvre P J ^a   Scheen, A J ^a,b  

^a CHU SART TILMAN   (Belgium)

^b UNIVERSITY OF LIÈGE   (Belgium)

Author keywords

Disposition index; Gastroplasty; Insulin secretion; Insulin sensitivity; Intravenous glucose tolerance test

Indexed keywords

C PEPTIDE;

ARTICLE; BODY MASS; BODY WEIGHT; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; FEMALE; GASTROPLASTY; GLUCOSE METABOLISM; GLUCOSE TOLERANCE TEST; HORMONE ACTION; HUMAN; INSULIN RELEASE; INSULIN SENSITIVITY; OBESITY; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

BODY WEIGHT; FEMALE; GASTROPLASTY; GLUCOSE; GLUCOSE TOLERANCE TEST; HUMANS; INSULIN; METABOLIC CLEARANCE RATE; OBESITY; POSTOPERATIVE PERIOD;

EID: 2342606345     PISSN: 03070565     EISSN: None     Source Type: Journal    
DOI: 10.1038/sj.ijo.0802632     Document Type: Article

References (15)

1. Mokdad AH, Bowman BA, Ford ES, Vinicor F, Marks JS, Koplan JP. The continuing epidemics of obesity and diabetes in the United States. JAMA 2001; 286: 1195-2000.
2. Scheen AJ, Paquot N, Letiexhe M, Paolisso G, Castillo MJ, Lefèbvre PJ. Glucose metabolism in obese subjects: lessons from OGTT, IVGTT, and clamp studies. Int J Obes Relat Metab Disord 1995; 19 (Suppl): S14-S20.
3. Scheen AJ. Current management strategies for coexisting diabetes mellitus and obesity. Drugs 2003; 63: 1165-1184.
4. Castillo MJ, Scheen AJ, Jandrain B, Lefèbvre PJ. Relationships between metabolic clearance rate of insulin and body mass index in a female population ranging from anorexia nervosa to severe obesity. Int J Obes Relat Metab Disord 1994; 18: 47-53.
5. Pereira JA, Claro BM, Pareja JC, Chaim EA, Astiarraga BD, Saad MJA, Muscelli E. Restored insulin inhibition on insulin secretion in nondiabetic severely obese patients after weight loss induced by bariatric surgery. Int J Obes Relat Metab Disord 2003; 27: 463-468.
6. Muscelli E, Pereira JA, Lazarin MACT, Silva CA, Pareja JC, Saad MJA. Lack of insulin inhibition on insulin secretion in nondiabetic morbidly obese patients. Int J Obes Relat Metab Disord 2001; 25: 798-804.
7. Scheen A, Castillo M, Paolisso G, Jandrain B, Lefèbvre PJ. Normal feedback inhibition of insulin secretion by insulin but reduced metabolic clearance rate of the hormone in obese subjects. In: Ailhaud G, Guy-Grand B, Lafontaine M, Ricquier D (eds). Obesity in Europe 91. John Libbey & Co.: London; 1992. pp 201-205.
8. Jimenez J, Zuniga-Guajardo S, Zinman B, Angel A. Effects of weight loss in massive obesity on insulin and C-peptide dynamics: sequential changes in insulin production, clearance, and sensitivity. J Clin Endocrinol Metab 1987; 64: 661-668.
9. Letiexhe MR, Scheen AJ, Gérard PL, Desaive C, Lefèbvre PJ. Insulin secretion, clearance and action before and after gastroplasty in severely obese subjects. Int J Obes Relat Metab Disord 1994; 18: 295-300.
10. Letiexhe MR, Scheen AJ, Gérard PL, Desaive C, Lefèbvre PJ. Postgastroplasty recovery of ideal body weight normalizes glucose and insulin metabolism in obese women. J Clin Endocrinol Metab 1995; 80: 364-369.
11. Kahn SE, Prigeon RL, McCulloch DK, Boyko EJ, Bergman RN, Schwartz MW, Neifin JL, Ward WK, Beard JC, Palmer JP, Porte D. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects. Diabetes 1993; 42: 1663-1672.
12. Bergman RN, Ader M, Huecking K, Van Gitters G. Accurate assessment of β-cell function. Diabetes 2002; 51 (Suppl 1): S212-S220.
13. Stumvoll M, Tataranni A, Stefan N, Vozarova B, Bogardus C. Persectives in diabetes. Glucose Allostasis. Diabetes 2003; 52: 903-909.
14. Letiexhe MR, Scheen AJ, Desaive C, Lefèbvre PJ. Hyperbolic relationship between changes in insulin secretion and action in obese subjects after gastroplasty (Abstract). Diabetologia 1995; 38 (Suppl 1): A158.
15. Sjöström CD, Peltonen M, Wedel H, Sjöström L. Differentiated long-term effects of intentional weight loss on diabetes and hypertension. Hypertension 2000; 36: 20-25.